Supercooled Smectic Nanoparticles: A Potential Novel Carrier System for Poorly Water Soluble Drugs

AbstractPurpose. The possibility of preparing nanoparticles in the supercooled thermotropic liquid crystalline state from cholesterol esters with saturated acyl chains as well as the incorporation of model drugs into the dispersions was investigated using cholesteryl myristate (CM) as a model cholesterol ester. Methods. Nanoparticles were prepared by high-pressure melt homogenization or solvent evaporation using phospholipids, phospholipid/bile salt, or polyvinyl alcohol as emulsifiers. The physicochemical state and phase behavior of the particles was characterized by particle size measurements (photon correlation spectroscopy, laser diffraction with polarization intensity differential scattering), differential scanning calorimetry, X-ray diffraction, and electron and polarizing light microscopy. The viscosity of the isotropic and liquid crystalline phases of CM in the bulk was investigated in dependence on temperature and shear rate by rotational viscometry. Results. CM nanoparticles can be obtained in the smectic phase and retained in this state for at least 12 months when stored at 23°C in optimized systems. The recrystallization tendency of CM in the dispersions strongly depends on the stabilizer system and the particle size. Stable drug-loaded smectic nanoparticles were obtained after incorporation of 10% (related to CM) ibuprofen, miconazole, etomidate, and 1% progesterone. Conclusions. Due to their liquid crystalline state, colloidal smectic nanoparticles offer interesting possibilities as carrier system for lipophilic drugs. CM nanoparticles are suitable model systems for studying the crystallization behavior and investigating the influence of various parameters for the development of smectic nanoparticles resistant against recrystallization upon storage.

[1]  Heike Bunjes,et al.  Crystallization tendency and polymorphic transitions in triglyceride nanoparticles , 1996 .

[2]  Y. Carpentier,et al.  Advances in Intravenous Lipid Emulsions , 2000, World Journal of Surgery.

[3]  Rainer H. Müller,et al.  Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN) dispersions , 1998 .

[4]  G. Ginsburg,et al.  Physical properties of cholesteryl esters. , 1986, Progress in lipid research.

[5]  Amarnath Sharma,et al.  Liposomes in drug delivery: Progress and limitations , 1997 .

[6]  G. Rapp,et al.  A dual detector single readout system for simultaneous small (SAXS) and wide-angle X-ray (WAXS) scattering , 1995 .

[7]  B. Kronberg,et al.  A method for the preparation of submicron particles of sparingly water-soluble drugs by precipitation in oil-in-water emulsions. I: Influence of emulsification and surfactant concentration. , 1993, Journal of pharmaceutical sciences.

[8]  J. Bordas,et al.  X-ray diffraction and scattering on disordered systems using synchrotron radiation , 1983 .

[9]  A. Buzaid,et al.  Association of carmustine with a lipid emulsion: in vitro, in vivo and preliminary studies in cancer patients , 2002, Cancer Chemotherapy and Pharmacology.

[10]  K. Mäder,et al.  Solid lipid nanoparticles: production, characterization and applications. , 2001, Advanced drug delivery reviews.

[11]  Raymond A. Firestone.  Low-Density Lipoprotein as a Vehicle for Targeting Antitumor Compounds to Cancer Cells , 1994 .

[12]  K. Westesen,et al.  Investigation of the gel formation of phospholipid-stabilized solid lipid nanoparticles , 1997 .

[13]  K. Westesen,et al.  Physicochemical Characterization of Protein-Free Low Density Lipoprotein Models and Influence of Drug Loading , 2004, Pharmaceutical Research.

[14]  Dmitri I. Svergun,et al.  PRIMUS: a Windows PC-based system for small-angle scattering data analysis , 2003 .

[15]  K. Westesen,et al.  Characterization of native and drug-loaded human low density lipoproteins. , 1995, Journal of pharmaceutical sciences.

[16]  H. Bunjes,et al.  Influence of emulsifiers on the crystallization of solid lipid nanoparticles. , 2003, Journal of pharmaceutical sciences.

[17]  R. Porter,et al.  Evaluation of Thermal Transitions in Some Cholesteryl Esters of Saturated Aliphatic Acids , 1970 .

[18]  M. Ala-Korpela,et al.  Structure of low density lipoprotein (LDL) particles: basis for understanding molecular changes in modified LDL. , 2000, Biochimica et biophysica acta.

[19]  H. Bunjes,et al.  Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential , 1997 .

[20]  T. Malkin.  The polymorphism of glycerides , 1954 .

[21]  G. Shipley,et al.  Interactions of cholesterol esters with phospholipids: cholesteryl myristate and dimyristoyl lecithin. , 1979, Journal of lipid research.

[22]  R. Finsy,et al.  Particle sizing by quasi-elastic light scattering , 1994 .

[23]  R. Porter,et al.  The Viscosity of Mesophases Formed by Cholesteryl Myristate , 1969 .

[24]  M. Phillips,et al.  Phase behavior of cholesteryl ester dispersions which model the inclusions of foam cells. , 1990, Biochemistry.

[25]  C. W. Hoerr,et al.  The role of X-ray diffraction in studies of the crystallography of monoacid saturated triglycerides , 1968 .

[26]  J. Wendorff,et al.  The Structure of Mesophases of Cholesteryl Esters , 1973 .

[27]  C. Washington,et al.  Release rate measurements of model hydrophobic solutes from submicron triglyceride emulsions , 1995 .

[28]  J. C. Gilkey,et al.  Cryo-electron microscopy reveals human low density lipoprotein substructure. , 1994, Journal of lipid research.